Literature DB >> 8446012

Influence of dietary egg and soybean phospholipids and triacylglycerols on human serum lipoproteins.

B C O'Brien1, V G Andrews.   

Abstract

Human serum lipid and lipoprotein concentrations and compositions were compared in ten healthy middle-aged men consuming phospholipids from egg or from soybean or triacylglycerol mixtures with fatty acid compositions similar to that of the phospholipids. All subjects followed each of the four treatments: egg phospholipids (EP), soybean phospholipids (SP), an oil of fatty acid composition similar to that of EP, and an oil similar in fatty acid composition to SP for six weeks with "wash-out" periods of similar duration between treatment periods. The phospholipids, 15 g/d, and the oils, 12 g/d, which contained approximately equivalent quantities of fatty acids were provided to the subjects in gelatin capsules and were taken before meals. Diet intake was monitored by three-day food records. Serum lipoproteins (Lp) were separated by ultracentrifugation into very low density lipoproteins, low density lipoproteins (LDL), high density lipoproteins (HDL)2 and HDL3. Lp fractions and whole serum were analyzed for triacylglycerols, cholesterol (CH), phospholipids (PL), and protein. HDL cholesterol was determined in whole serum. Cholesteryl esters were determined in some Lp fractions. Lipid compositions of Lp were expressed in mmol/g protein. Apoprotein B was measured in whole serum and in LDL; apoprotein A-I in whole serum and in HDL3. In whole serum, CH and PL were significantly lower after the SP compared to EP treatment periods. CH, but not PL, was lower after SPTG compared to EP. CH in HDL2 was significantly higher after SP compared to SPTG. Also, PL in HDL2 were significantly higher after SP compared to all other treatments and to baseline.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446012     DOI: 10.1007/bf02536352

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  33 in total

1.  Studies on the synthesis and secretion of serum lipoproteins by rat liver slices.

Authors:  C M RADDING; D STEINBERG
Journal:  J Clin Invest       Date:  1960-10       Impact factor: 14.808

Review 2.  Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

Authors:  D Reichl; N E Miller
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

3.  Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel.

Authors:  N Muñiz
Journal:  Clin Chem       Date:  1977-10       Impact factor: 8.327

4.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

5.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

6.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Authors:  M J Stampfer; F M Sacks; S Salvini; W C Willett; C H Hennekens
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

7.  Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster.

Authors:  D K Spady; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intravenous injection of saturated and polyunsaturated lecithins.

Authors:  C W Adams; Y H Abdulla; O B Bayliss; R S Morgan
Journal:  J Pathol Bacteriol       Date:  1967-07

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Effect of shellfish consumption on cholesterol absorption in normolipidemic men.

Authors:  M T Childs; C S Dorsett; A Failor; L Roidt; G S Omenn
Journal:  Metabolism       Date:  1987-01       Impact factor: 8.694

View more
  6 in total

1.  Lipids rich in phosphatidylethanolamine from natural gas-utilizing bacteria reduce plasma cholesterol and classes of phospholipids: a comparison with soybean oil.

Authors:  Hanne Müller; Lars I Hellgren; Elisabeth Olsen; Anders Skrede
Journal:  Lipids       Date:  2004-09       Impact factor: 1.880

2.  Long term effects on human plasma lipoproteins of a formulation enriched in butter milk polar lipid.

Authors:  Lena Ohlsson; Hans Burling; Ake Nilsson
Journal:  Lipids Health Dis       Date:  2009-10-16       Impact factor: 3.876

3.  "Essential" phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease.

Authors:  A N Klimov; V O Konstantinov; B M Lipovetsky; A S Kuznetsov; V T Lozovsky; V F Trufanov; S L Plavinsky; K J Gundermann; R Schumacher
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

4.  Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers.

Authors:  Stine M Ulven; Bente Kirkhus; Amandine Lamglait; Samar Basu; Elisabeth Elind; Trond Haider; Kjetil Berge; Hogne Vik; Jan I Pedersen
Journal:  Lipids       Date:  2010-11-02       Impact factor: 1.880

Review 5.  Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Molecules       Date:  2017-11-14       Impact factor: 4.411

Review 6.  Marine omega-3 phospholipids: metabolism and biological activities.

Authors:  Lena Burri; Nils Hoem; Sebastiano Banni; Kjetil Berge
Journal:  Int J Mol Sci       Date:  2012-11-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.